| meta-analysis | Q815382 |
| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Samuel Murray | |
| Issa J. Dahabreh | |||
| P2860 | cites work | Distribution of HER2 V655 genotypes in breast cancer cases and controls in the United States | Q24170311 |
| The case of the misleading funnel plot | Q24676535 | ||
| Bias in meta-analysis detected by a simple, graphical test | Q24685585 | ||
| Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
| Meta-analysis in clinical trials | Q27860779 | ||
| Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland | Q28140600 | ||
| How should meta-regression analyses be undertaken and interpreted? | Q28193388 | ||
| No adjustments are needed for multiple comparisons | Q28292261 | ||
| Cancer statistics, 2009 | Q29547625 | ||
| A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints | Q29614902 | ||
| Replication validity of genetic association studies | Q29615456 | ||
| The genetic association database | Q29617244 | ||
| Comprehensive analysis of the ATM, CHEK2 and ERBB2 genes in relation to breast tumour characteristics and survival: a population-based case-control and follow-up study | Q30478981 | ||
| Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data | Q30955211 | ||
| Early extreme contradictory estimates may appear in published research: the Proteus phenomenon in molecular genetics research and randomized trials | Q31170846 | ||
| Statistics notes. The odds ratio | Q33817703 | ||
| Epidemiology of breast cancer. | Q34570046 | ||
| Tracking the epidemiology of human genes in the literature: the HuGE Published Literature database | Q36461180 | ||
| TP53 Arg72Pro polymorphism and colorectal cancer risk: a systematic review and meta-analysis | Q37771127 | ||
| Commonly studied single-nucleotide polymorphisms and breast cancer: results from the Breast Cancer Association Consortium | Q40282176 | ||
| Genetic susceptibility to breast cancer | Q41130542 | ||
| A re-evaluation of random-effects meta-analysis. | Q41866179 | ||
| Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk | Q43565323 | ||
| Germ-line HER-2 variant and breast cancer risk by stage of disease | Q43814381 | ||
| Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk | Q44237693 | ||
| 'Racial' differences in genetic effects for complex diseases | Q44586727 | ||
| Common genetic variants for breast cancer: 32 largely refuted candidates and larger prospects | Q44834778 | ||
| A bias in genotyping the ERBB2 (HER2) Ile655Val variant | Q46462920 | ||
| Reply: a bias in genotyping of the ERBB2 (HER2) Ile655Val variant | Q46598623 | ||
| HER2 codon 655 polymorphism and risk of breast cancer in African Americans and whites. | Q47779023 | ||
| In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias | Q51967379 | ||
| High constant incidence in twins and other relatives of women with breast cancer | Q53403578 | ||
| Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk. | Q53412908 | ||
| A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea | Q53619056 | ||
| Impact of Violations and Deviations in Hardy-Weinberg Equilibrium on Postulated Gene-Disease Associations | Q57542910 | ||
| Improved tests for a random effects meta-regression with a single covariate | Q73855792 | ||
| Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study | Q74157664 | ||
| Re: Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk | Q77137526 | ||
| Polygenic susceptibility to breast cancer and implications for prevention | Q78029012 | ||
| ERBB2 genetic polymorphism and breast cancer risk in Chinese women: a population-based case-control study | Q80769623 | ||
| Role of the HER2 [Ile655Val] genetic polymorphism in tumorogenesis and in the risk of trastuzumab-related cardiotoxicity | Q80785284 | ||
| HER2 codon 655 polymorphism and breast cancer risk: a meta-analysis | Q81157917 | ||
| HER2 codon 655 polymorphism and breast cancer: results from kin-cohort and case-control analyses | Q81491369 | ||
| Polygenes, risk prediction, and targeted prevention of breast cancer | Q81523323 | ||
| The Combination of Estimates from Different Experiments | Q100745541 | ||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | single-nucleotide polymorphism | Q501128 |
| systematic review | Q1504425 | ||
| P304 | page(s) | 503-509 | |
| P577 | publication date | 2011-04-07 | |
| P1433 | published in | Cancer Epidemiology | Q325968 |
| P1476 | title | Lack of replication for the association between HER2 I655V polymorphism and breast cancer risk: a systematic review and meta-analysis | |
| Lack of replication for the association between HER2 I655V polymorphism and breast cancer risk: A systematic review and meta-analysis | |||
| P478 | volume | 35 |
| Q35879741 | Actionable pharmacogenetic markers for prediction and prognosis in breast cancer. |
| Q50909910 | Association of BRCA1, BRCA2, RAD51, and HER2 gene polymorphisms with the breast cancer risk in the Bangladeshi population |
| Q40212670 | Association of HER2 codon 655 polymorphism with ovarian cancer |
| Q37386163 | Associations with growth factor genes (FGF1, FGF2, PDGFB, FGFR2, NRG2, EGF, ERBB2) with breast cancer risk and survival: the Breast Cancer Health Disparities Study |
| Q36907956 | Biogenetic mechanisms predisposing to complex phenotypes in parents may function differently in their children |
| Q43466172 | Correlation of HER2, FCGR2A, and FCGR3A gene polymorphisms with trastuzumab related cardiac toxicity and efficacy in a subgroup of patients from UNICANCER-PACS04 trial |
| Q35997942 | Detection of HER2 Gene Polymorphism in Breast Cancer: PCR Optimization Study |
| Q50265827 | Detection of novel germline mutations for breast cancer in non-BRCA1/2 families |
| Q24810389 | ERBB2 in cat mammary neoplasias disclosed a positive correlation between RNA and protein low expression levels: a model for erbB-2 negative human breast cancer |
| Q28084565 | ErbB polymorphisms: insights and implications for response to targeted cancer therapeutics |
| Q51734194 | Genetic association between HER2 and ESR2 polymorphisms and ovarian cancer: a meta-analysis |
| Q36660906 | HER2 Ile655Val Single Nucleotide Polymorphism in Patients with Ovarian Cancer |
| Q44306520 | HER2 Ile655Val and PTEN IVS4 polymorphisms in patients with breast cancer. |
| Q50125137 | HER2 Ile655Val polymorphism is negatively associated with breast cancer susceptibility. |
| Q50877452 | Impact of HER2 codon 655 polymorphism and expression of HER2 and HER3 in non small cell lung cancer patients |
| Q37688976 | The impact of ERBB-family germline single nucleotide polymorphisms on survival response to adjuvant trastuzumab treatment in HER2-positive breast cancer |
Search more.